Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

934
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
934
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

299
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
299

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Karyoptosis mediates cell death and neurodegeneration upon proteotoxic stress.

Nature communications·2026
Same author

Infectious Diseases Fellowship Curriculum: IDSA Training Program Directors Community of Practice (TPDCOP), Curricular and Educational REsources Workgroup (CREW).

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Ethical Considerations in the Use of Indwelling Lines in Persons Who Use Injection Drugs.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Treatment Approaches for Refractory <i>Mycoplasma genitalium</i> Infection.

Open forum infectious diseases·2026
Same author

Advancing nutrition education: Harvard medical student reflections on a scalable online course.

The American journal of medicine·2026
Same author

A Blurry Line: Navigating Treatment Decisions When the Guidelines Don't Fit.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
查看所有相关文章

相关实验视频

Updated: Jun 24, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.4K

转换人类免疫缺陷病毒疗法:基本原则和选择

Danilo Bacic Lima1, Daniel A Solomon2

  • 1Massachusetts General Hospital and Brigham & Women's Hospital; Infectious Diseases Division, Brigham and Women's Hospital, 75 Francis Street, PBB-A4, Boston, MA 02115, USA. Electronic address: https://twitter.com/danbacic.

Infectious disease clinics of North America
|June 13, 2024
PubMed
概括
此摘要是机器生成的。

新的抗逆转录病毒疗法 (ART) 选择为艾滋病毒治疗提供了更好的安全性,耐受性和便利性. 本指南有助于临床医生决定何时以及如何将患者转换为更有效的ART疗法.

关键词:
艺术 艺术 艺术 艺术抗逆转录病毒药物的使用.艾滋病病毒 艾滋病病毒 艾滋病病毒开关 开关 开关 开关 开关

更多相关视频

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.8K
Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.7K

相关实验视频

Last Updated: Jun 24, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.4K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.8K
Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.7K

科学领域:

  • 传染性疾病 传染性疾病
  • 病毒学 病毒学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 对艾滋病毒的有效抗逆转录病毒疗法 (ART) 选择正在扩大.
  • 虽然旧的ART疗法实现了病毒抑制,但新的选择提供了更好的安全性,耐受性和方便性.

研究的目的:

  • 为转换ART疗法提供指导原则.
  • 为了突出启动ART开关的原因.
  • 概述选择新的ART治疗方案的关键因素.

主要方法:

  • 对当前ART指南和临床试验数据的文献综述.
  • 分析各种ART治疗方案的安全性,耐受性和方便性.
  • 为ART疗法选择制定决策框架.

主要成果:

  • 确定需要ART切换的特定临床情景.
  • 基于有效性,安全性和以患者为中心的结果评估新的ART选择.
  • 在选择治疗方案时考虑药物相互作用,并发病症和患者的坚持.

结论:

  • 切换ART可以通过利用新的,更有利的治疗方案来优化治疗结果.
  • 对ART选择的系统方法可确保提高患者的安全性,耐受性和方便性.
  • 个性化的ART策略对于长期的艾滋病毒管理和病毒抑制至关重要.